1. Home
  2. UBX vs HUIZ Comparison

UBX vs HUIZ Comparison

Compare UBX & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • HUIZ
  • Stock Information
  • Founded
  • UBX 2009
  • HUIZ 2006
  • Country
  • UBX United States
  • HUIZ China
  • Employees
  • UBX N/A
  • HUIZ N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • HUIZ Specialty Insurers
  • Sector
  • UBX Health Care
  • HUIZ Finance
  • Exchange
  • UBX Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • UBX 18.4M
  • HUIZ 18.8M
  • IPO Year
  • UBX 2018
  • HUIZ 2020
  • Fundamental
  • Price
  • UBX $0.75
  • HUIZ $2.26
  • Analyst Decision
  • UBX Strong Buy
  • HUIZ
  • Analyst Count
  • UBX 3
  • HUIZ 0
  • Target Price
  • UBX $5.33
  • HUIZ N/A
  • AVG Volume (30 Days)
  • UBX 141.5K
  • HUIZ 65.5K
  • Earning Date
  • UBX 04-22-2025
  • HUIZ 05-27-2025
  • Dividend Yield
  • UBX N/A
  • HUIZ N/A
  • EPS Growth
  • UBX N/A
  • HUIZ N/A
  • EPS
  • UBX N/A
  • HUIZ N/A
  • Revenue
  • UBX N/A
  • HUIZ $171,105,205.00
  • Revenue This Year
  • UBX N/A
  • HUIZ $6.81
  • Revenue Next Year
  • UBX N/A
  • HUIZ $9.30
  • P/E Ratio
  • UBX N/A
  • HUIZ N/A
  • Revenue Growth
  • UBX N/A
  • HUIZ 4.46
  • 52 Week Low
  • UBX $0.85
  • HUIZ $1.50
  • 52 Week High
  • UBX $3.10
  • HUIZ $10.58
  • Technical
  • Relative Strength Index (RSI)
  • UBX 28.49
  • HUIZ 54.25
  • Support Level
  • UBX $0.70
  • HUIZ $2.10
  • Resistance Level
  • UBX $0.95
  • HUIZ $2.43
  • Average True Range (ATR)
  • UBX 0.10
  • HUIZ 0.29
  • MACD
  • UBX -0.01
  • HUIZ 0.06
  • Stochastic Oscillator
  • UBX 8.49
  • HUIZ 73.44

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: